Reducing Colorectal Cancer Death Through Mailed Outreach Screening

NACompletedINTERVENTIONAL
Enrollment

782

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 12, 2017

Study Completion Date

December 30, 2017

Conditions
Colorectal Cancer
Interventions
OTHER

Mailed-FIT

The FIT is analyzed at the Philadelphia VAMC by an auto-analyzer system that provides quantitative results corresponding to the concentration of hemoglobin in the collected sample. Specimens will be analyzed according to manufacturer's instructions to minimize potential degradation of hemoglobin. Results are provided as positive if the hemoglobin concentration is 100ng/dL. The machine records (but does not report) the quantitative results of the hemoglobin concentration in the sample, which we will seek to obtain from the laboratory for future studies.

OTHER

Screening invitation-reminder

These patients will continue to receive UC. They will in addition receive an invitation letter with all of the information about CRC testing in the mail-FIT arm

Trial Locations (1)

19104

Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, Philadelphia

All Listed Sponsors
collaborator

University of Pennsylvania

OTHER

lead

VA Office of Research and Development

FED

NCT02584998 - Reducing Colorectal Cancer Death Through Mailed Outreach Screening | Biotech Hunter | Biotech Hunter